Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effects of Sedatives on Tobacco Use Disorder
NCT03813121Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Tobacco Use Disorder (TUD) comparing midazolam intravenous infusion, placebo intravenous infusion and ketamine intravenous infusion (3 arms). Primary endpoint: Side Effects at 1 week. Started Jun 2019; status: completed.
02
Drugs
midazolamketamine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03813121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03813121.